Cytosorbents Corporation
CTSO
$1.10
-$0.06-5.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -76.79% | -31.99% | -35.68% | -54.81% | -36.19% |
| Total Receivables | 20.84% | 7.35% | 11.36% | 22.39% | 6.92% |
| Inventory | -19.04% | 9.09% | 110.99% | 116.65% | -2.48% |
| Prepaid Expenses | 78.29% | -40.90% | -4.56% | -52.75% | -26.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -14.94% | -13.83% | -7.14% | -29.02% | -24.77% |
|
|
|||||
| Total Current Assets | -14.94% | -13.83% | -7.14% | -29.02% | -24.77% |
| Net Property, Plant & Equipment | -7.24% | -6.93% | -7.10% | -6.44% | -5.28% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -4.06% | -- | -- | -- | -11.02% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.91% | 76.23% | 71.96% | -11.89% | -11.44% |
| Total Assets | -10.55% | 0.48% | 1.87% | -18.09% | -16.25% |
|
|
|||||
| Total Accounts Payable | -12.16% | -32.06% | 7.44% | -19.88% | 129.71% |
| Total Accrued Expenses | -4.82% | -18.98% | 0.72% | 14.43% | -22.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -84.25% | -54.55% | 260.23% | 2,491.94% | 2,538.75% |
| Total Finance Division Other Current Liabilities | -45.84% | -48.56% | -30.27% | -1.33% | 56.41% |
| Total Other Current Liabilities | -45.84% | -48.56% | -30.27% | -1.33% | 56.41% |
| Total Current Liabilities | -30.01% | -29.59% | -0.14% | 28.63% | 44.48% |
|
|
|||||
| Total Current Liabilities | -30.01% | -29.59% | -0.14% | 28.63% | 44.48% |
| Long-Term Debt | 450.41% | 228.81% | 172.30% | -61.51% | -49.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.51% | -2.51% | -2.29% | -2.07% | -1.87% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 23.03% | 19.76% | 29.42% | -1.28% | 5.81% |
|
|
|||||
| Common Stock & APIC | 1.51% | 5.58% | 5.97% | 6.06% | 6.69% |
| Retained Earnings | -7.31% | -6.75% | -9.54% | -10.54% | -11.53% |
| Treasury Stock & Other | 703.33% | -105.26% | 63.65% | 1.83% | -77.28% |
| Total Common Equity | -52.70% | -29.78% | -30.54% | -34.63% | -33.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -52.70% | -29.78% | -30.54% | -34.63% | -33.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -52.70% | -29.78% | -30.54% | -34.63% | -33.62% |
|
|
|||||